Pneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae

Keywords

Streptococcus pneumoniae, Virulence, Microbiology, Biology, Virulence factor

References

• Interaction of gram-positive microorganisms with complement.Simon Duffy — 1985
• The human complement system in health and diseaseJ. Volanakis — 1998
• Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.Joachim Weis, S.K. Alex Law, R. P. Levine — 1985
• GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICEPhillip J. Baker, Diana F. Amsbaugh, Benjamin Prescott — 1976
• Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.Rick A. Wetsel, D T Fleischer, David L. Haviland — 1990
• Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.J A Winkelstein, Aaron S. Abramovitz, Alexander Tomasz — 1980
• Identification of the IgA-binding region in streptococcal protein Arp.Eskil Johnsson, Gunnar Andersson, Gunnar Lindahl — 1994
• Abrogation of the alternative complement pathway by targeted deletion of murine factor B.Mitsuru Matsumoto, Wataru Fukuda, Antonella Circolo — 1997
• The Human Complement System in Health and Disease.B. Paul Morgan — 1998
• Solid Phase Enzyme Immunoassays for the Quantification of Serum Amyloid P (SAP) and Complement Component 3 (C3) Proteins in Acute-Phase Mouse SeraY.S. Taktak, BRIDGET E. STENNING — 1992
• Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection.John Farley, James C. King, Prasanna Nair — 1994
• Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.David Gordon, Jessica L. Rice, John J. Finlay‐Jones — 1988
• Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA.Antonella Circolo, Gérard Garnier, Wataru Fukuda — 1999
• GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICEDiana F. Amsbaugh, Carl T. Hansen, Benjamin Prescott — 1972
• Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniaeLarry S. McDaniel, G Scott, John F. Kearney — 1984
• Contribution of novel choline‐binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniaeCarsten Rosenow, Patricia Ryan, Jeffrey N. Weiser — 1997
• Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice.Rebecca Creech Tart, Larry S. McDaniel, Beth A. Ralph — 1996
• Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniaeDavid E. Briles, Moon H. Nahm, Kenneth R. Schroer — 1981
• Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniaeMarilyn J. Crain, W. D. Waltman, Jennifer S. Turner — 1990
• Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA geneJanet Yother, G L Handsome, David E. Briles — 1992

Cited by

• The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in miceJeremy Brown, Tracy Hussell, Sarah M. Gilliland — 2002
• PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by ApolactoferrinAndrés Acosta González, José Manuel Molinero Barroso — 2004
• Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media.Robert Baird — 2007
• Immunomodulatory effect of pneumolysin upon CD4 T cellsG. Meiklejohn — 2004
• Versatility of choline metabolism and choline-binding proteins in Streptococcus pneumoniae and commensal streptococci.Rupa Mahanti — 2009
• Virulence of pneumococcal proteins on the inner ear.Jonathan Culpeper — 2009
• Streptococcus pneumoniae: infection, inflammation and disease.Timothy J. Mitchell — 2006
• Functional activities of C-reactive protein on neutrophilsJ. Rodríguez — 2004
• Prevalence and load of airway bacteria in chronic obstructive pulmonary diseaseDS Garcha — 2014
• Screening of streptococcus pneumoniae ABC transporters for their role in virulence and investigation of their lipoprotein components as vaccine candidatesShilpa Basavanna — 2011
• Interactions of soluble complement regulators with pathogenic bacteriaHanna Jarva — 2004
• New approach for the treatment of pneumococcal diseasesMafalda Pires Damaso — 2011
• Characterization of host and microbe interactions affecting adherence, clearance and systemic spread of S. pneumoniaeSofia Dahlberg — 2009
• Microbial factors and host responses affecting severity of pneumococcal disease and pneumococcal carriageA. Sandgren — 2005
• Interplay of virulence factors in complement resistance of Streptococcus pneumoniaeMerit Melin — 2011
• Studies on emergence and spread of antibiotic resistant Streptococcus pneumoniaeDiana Karlsson — 2010
• Species-specific interaction of Streptococcus pneumoniae with human complement factor HLing Lu, Zhuo Ma, T. Sakari Jokiranta — 2008
• Molecular pathogenesis of pneumococcal pneumonia.A. McCullers Jonathan — 2001
• Genetic approaches towards understanding penumococcal virulence and biologyJ. Fernebro — 2007
• The Host Immune Regulator Factor H Interacts via Two Contact Sites with the PspC Protein of Streptococcus pneumoniae and Mediates Adhesion to Host Epithelial Cells1Sven Hammerschmidt, Vaibhav Agarwal, Anja Kunert — 2007

Related papers

• Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.Hugo E. Jasin — 1972
• Deficient Alternative Complement Pathway Activity in Newborn SeraElaine L. Mills, Bengt Björkstén, Paul G. Quie — 1979
• Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acid.Arne Forsgren, Paul G. Quie — 1974
• A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.M. Yamamura, Helgi Valdimarsson — 1978
• Pneumococcal type-associated variability in alternate complement pathway activationDouglas P. Fine — 1975
• Influence of the Alternate Complement Pathway on Opsonization of Several Bacterial SpeciesArne Forsgren, Paul G. Quie — 1974
• ROLE OF ANTIBODY AND THE CLASSICAL AND ALTERNATIVE COMPLEMENT PATHWAYS ON THE OPSONIZATION OF GROUP B STREPTOCOCCIAnn O. Shigeoka, Robert T. Hall, Val G. Hemming — 1977
• Evidence for Quantitative Variability of Bacterial Opsonic RequirementsJ. C. Guckian, Wayne Christensen, Douglas P. Fine — 1978
• Opsonic requirements for phagocytosis of Legionella micdadei by polymorphonuclear leukocytesD O Steffensen, D. L. Weinbaum, John Dowling — 1985